{"id":2519,"date":"2017-10-12T22:46:34","date_gmt":"2017-10-12T22:46:34","guid":{"rendered":"https:\/\/www.medicalmarijuanainc.com\/?p=29868"},"modified":"2017-10-12T22:46:34","modified_gmt":"2017-10-12T22:46:34","slug":"new-survey-neurologist-dr-carlos-aguirre-demonstrates-efficacy-cbd-seizures","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2017\/10\/12\/new-survey-neurologist-dr-carlos-aguirre-demonstrates-efficacy-cbd-seizures\/","title":{"rendered":"New Survey from Neurologist Dr. Carlos Aguirre Demonstrates Efficacy of CBD on Seizures"},"content":{"rendered":"

[vc_row][vc_column][vc_column_text]<\/p>\n

Continued studies from Dr. Aguirre further reveal the advantages of a CBD treatment option for those suffering from seizures.<\/span><\/i><\/h3>\n

Noted pediatric neurologist Dr. Carlos G. Aguirre-Velazquez today revealed the positive results of a <\/span>recent clinical study<\/span><\/a> exploring the efficacy of CBD oil on seizures. The study, which mainly utilized RSHO-X\u2122, the flagship product of HempMeds\u00ae Mexico, targeted patients diagnosed with tuberous sclerosis complex (TSC). <\/span><\/p>\n

\u201cWe congratulate Dr. Aguirre for his work in unveiling, like he did in this study, that not only is CBD effective in relieving seizures, but also exhibiting that CBD can be used over long periods of time without harm, compared to antiepileptic or broad-spectrum steroids that can have dangerous side effects if used for several years, including vision and damage to major organs,\u201d said Dr. Stuart Titus, CEO of Medical Marijuana, Inc.<\/span><\/p>\n

Brief Overview of the Study<\/b><\/p>\n

Dr. Aguirre\u2019s work primarily measured the reduction in frequency, intensity, and duration of convulsive crises in people with TSC and saw promising results from cannabidiol (CBD) as a treatment for patients with TSC. Also recorded in the study were quality of life, dependence on heavy prescription drugs, and long-term sustainability of treatment with CBD.<\/span><\/p>\n

The trial comprised patients with varying forms of epilepsy, but the majority in the study have been diagnosed with TSC, a genetic disorder characterized by the growth of noncancerous (benign) tumors in many parts of the body, including the brain, which can lead to convulsive crises. Tumors can lead to significant health problems, especially when they strike organs, especially major ones such as: <\/span><\/p>\n